caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1730136607

Xiao-Ke GaoM.D.

NeurologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
440
Unique beneficiaries
—
Total services
1,620
Distinct HCPCS
17
Medicare payment
$105K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,430 Neurology providers in NY — above median (cohort median 560).
REFERRAL NETWORK

Where Xiao-Ke Gao's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Sherwin Cristobal
Physical Therapist in Private Practice · Bronx, NY
141643
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
72225
Sirisha Tikko
Physical Medicine and Rehabilitation · New York, NY
4195
CHARLES B. WANG COMMUNITY HEALTH CENTER, INC.2972
TRASI, SUNIL2848
BETH ISRAEL MEDICAL CENTER2678
Jian Liang
Podiatry · New York, NY
2337
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2241
Calvin Lo
Diagnostic Radiology · New York, NY
2252
Empire City Laboratories, Inc
Clinical Laboratory · Brooklyn, NY
1439
Heather Osborne
Diagnostic Radiology · New York, NY
1321
Barbara Kuang
Diagnostic Radiology · New York, NY
1323
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
97.8
Quality
95.6
Cost
82.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.96%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
2,767
Beneficiaries
—
Total drug cost
$34K
Distinct drugs
37
Brand share
11.5%
Top prescribed drugs
Donepezil Hcl902 claims
Mirtazapine348 claims
Gabapentin209 claims
Tizanidine Hcl167 claims
Quetiapine Fumarate134 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.